Filter
946
Filtered Results: 946
Text search:
modes
of
transmission
Featured
Recommendations
87
New Publications
286
Language
Document type
No document type
559
Guidelines
150
Studies & Reports
93
Strategic & Response Plan
50
Manuals
47
Training Material
21
Fact sheets
9
Situation Updates
7
Online Courses
4
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
Congo, Democratic Republic of
39
India
30
Sierra Leone
29
Kenya
29
Liberia
27
Global
26
Burkina Faso
25
Nigeria
24
Senegal
23
Rwanda
20
Africa
19
Malawi
18
Guinea
17
Zambia
17
Ethiopia
16
Western and Central Europe
16
Nepal
15
Mali
14
Côte d’Ivoire / Ivory Coast
13
Tanzania
13
Ghana
12
Uganda
12
South Africa
11
Lesotho
11
West and Central Africa
10
Haiti
8
Benin
8
Madagascar
8
Myanmar / Burma
8
Latin America and the Carribbean
8
Asia
7
Philippines
6
Namibia
6
Eastern Europe
6
Cameroon
5
Togo
5
Ukraine
5
South–East Asia Region
5
Niger
4
Pakistan
4
Chad
4
Cambodia
4
Bangladesh
4
Central African Republic
4
Eswatini/ Swaziland
4
East and Southern Africa
4
Russia
4
Zimbabwe
3
Mozambique
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Indonesia
2
Sudan
2
North Macedonia
2
Burundi
2
Armenia
2
South Sudan
1
Iraq
1
Afghanistan
1
Germany
1
Syria
1
Singapore
1
Papua New Guinea
1
Botswana
1
Mexico
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Estonia
1
Vietnam
1
France
1
Authors & Publishers
Publication Years
Category
Countries
367
Clinical Guidelines
88
Public Health
53
Key Resources
49
Women & Child Health
32
Capacity Building
20
Pharmacy & Technologies
13
Toolboxes
HIV
124
COVID-19
106
Rapid Response
76
Ebola
70
TB
28
NTDs
27
Mental Health
26
Planetary Health
21
AMR
19
Zika
17
Caregiver
17
Conflict
11
Refugee
9
Cholera
7
Natural Hazards
7
Specific Hazards
7
Disability
5
Pharmacy
5
Global Health Education
4
Health Financing Toolbox
4
Polio
3
NCDs
2
Social Ethics
1
MSF International AIDS Working Group
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and C...
Clinician Outreach and Communication Activity (COCA) Call
April 12, 2016
This document provides interim guidance for effective risk communication around Zika virus transmission and potential complications. A causal relationship between Zika virus infection and these potential complications has not yet been proven. In thi...
Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPC published here describes the characteristics of new typ...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive rep...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive rep...
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential ...
In December 2019 a novel coronavirus (2019-nCoV) was identified as the causative agent of a severe acute respiratory illness among people exposed in a seafood market in Wuhan, China; • Human-to-human tra... has been documented, including in healthcare workers, and aerosol-generating procedures (AGP)† may play a role in the spread of the disease; • There are uncertainties in the natural history of the 2019-nCoV, including source(s), transmissibility mechanisms, viral shedding, and persistence of the virus in the environment and on fomites; • As of 6 February 2020, the following precautions are recommended for the care of patients with suspected or confirmed cases of 2019-nCoV: o For any suspected or confirmed cases of 2019-nCoV: standard + contact + droplet precautions o For any suspected or confirmed cases of 2019-nCoV and AGP: standard + contact + airborne precautions • The use of personal protective equipment (PPE) by healthcare workers requires an evaluation of the risk related to healthcare-related activities;
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk ... severe COVID-19, NPI are the most effective public health interventions against COVID-19. These ECDC guidelines detail available options for NPI in various epidemiologic scenarios, assess the evidence for their effectiveness and address implementation issues, including potential barriers and facilitators.
This checklist helps to identify the necessary measures to be implemented to mitigate infection transmission among travellers and ground-crossing staff in the context of the COVID-19 pandemic. It fe...
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodbor...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission ... the disease, and reducing spillover of the virus from animals to humans.
Mpox is a viral illness caused by the monkeypox virus (MPXV). It can cause a painful rash, enlarged lymph nodes and fever. Most people fully recover, but some get very sick. The virus transmits from person to person through close, including sexual, contact. It also has animal reservoirs in east, central and west Africa, where spillovers from animals to humans can occasionally occur, sparking further outbreaks.
There are two different clades of the virus: clade I and clade II. Clade I outbreaks are deadlier than clade II outbreaks.
A major emergence of mpox linked to clade II began in 2017, and since 2022, has spread to all regions of the world. Between July 2022 and May 2023, the outbreak was declared a Public Health Emergency of International Concern. While that outbreak has largely subsided, cases and deaths continue to be reported today, illustrating that low-level transmission continues around the world.
Currently, there is also a major outbreak of clade I virus in the Democratic Republic of the Congo (DRC), where cases have been on the rise for decades. Since the beginning of the year, over 6500 cases and 345 deaths have been reported in the DRC. Almost half of these are among children under the age of 15 years.
The Strategic framework for enhancing prevention and control of mpox (2024–2027) provides a roadmap for health authorities, communities, and stakeholders worldwide to control mpox outbreaks in every context, advance mpox research and access to countermeasures, and to minimize zoonotic transmission.
This brief focuses specifically on the Grand Nord (Great North): the Beni and Lubero territories of northern North Kivu that are the epicentre of the outbreak. Further participatory enquiry should b...
